1/28
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Invokamet
brand for Metformin and Canagliflozin
Glipizide (Glucotrol)
This sulfonylurea has no active metabolites
Linagliptin (Tradjenta)
This DPP-4 inhibitor requires no renal dose adjustment
GLP-1 agonists
Avoid this drug class in patients with gastroparesis
Thiazolidinediones
Contact your provider if you experience trouble breathing, swelling, and rapid weight gain after using a medication from this class
glucose-independent
Sulfonylureas display ______-_____ insulin secretion
administer with largest meal in evening OR switch to ER formulation
What to do for patients experiencing GI SEs from Metformin
vitamin B12
Deficiency of this vitamin may occur secondary to chronic Metformin use
similar mechanism of action without added benefit
Don't use DPP-4 inhibitors and GLP-1 agonists together for this reason
Rybelsus (Semaglutide)
the only oral GLP-1 agonist medication
beta-adrenergic antagonists (beta-blockers)
this class of medications can mask the signs of hypoglycemia when given with sulfonylureas
Saxagliptin (Onglyza)
this DPP-4 inhibitor can increase the risk of heart failure
upper belly pain
vomiting
belly tenderness
fever
tachycardia
Patients might report these symptoms of pancreatitis when using Mounjaro
Dapagliflozin (Farxiga)
Empagliflozin (Jardiance)
these 2 medications can be prescribed in patients with CHF or CKD without a history of DM
Gemfibrozil (Lopid)
Actos therapy should not exceed 15 mg when administered with this strong CYP2C8 inhibitor
Inpefa (Sotagliflozin)
this oral medication is the first and only SGLT-1 and SGLT-2 inhibitor
SGLT-2 inhibitors
Administration of this drug class in the morning is recommended to avoid nocturia
delayed gastric emptying = delayed OC absorption = decreased oral contraceptive levels.
counsel to take 1 hour before GLP-1RA and add a barrier contraceptive 4 weeks after initiation or dose increase
SS, a 33-year-old female, picks up a new prescription for Bydureon at your pharmacy. You notice her medication list also includes Loestrin. Explain the drug-drug interaction. How should you counsel her?
warfarin, lithium, digoxin
GLP-1RA can increase drug levels of these NTI meds
Pioglitazone
This medication can reduce the risk of ASCVD/MACE; however, it may increase the risk of heart failure
Fournier's gangrene
This rare, life-threatening bacterial infection of the genitals and perineum can be caused by SGLT-2 inhibitors
glucose tablets and glucose gels
Hypoglycemia caused by acarbose must be treated with these two specific agents
insulin and secretagogues
reduce the dose of these classes of medications when given with GLP-1RAs
Saxenda (Liraglutide)
Wegovy (Semaglutide)
Zepbound (Tirzepatide)
List the brand name and generic for GLP-1 RA agents indicated for treatment of obesity
Liraglutide
Don't recommend this GLP-1 agonist in patients desiring weekly injections
Trulicity
This brand name agent is approved for primary and secondary ASCVD prophylaxis.
Meglitinides
This class of medication should be taken orally TID 15-30 minutes prior to each meal
Ozempic
this medication utilizes the following titration schedule
Sulfonylureas and Meglitinides
Duplicate therapy of these secretagogues may cause severe hypoglycemia